Details about Karl Claxton

Access statistics for papers by Karl Claxton.

Last updated 2019-09-16. Update your information in the RePEc Author Service.

Short-id: pcl81

Working Papers

2019

1. Accounting for timing when assessing health-related policies
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (3)
   See also Journal Article Accounting for Timing when Assessing Health-Related Policies, Journal of Benefit-Cost Analysis, Cambridge University Press (2019) View citations (5) (2019)
2. Assessing health opportunity costs for the Indian health care systems
   Working Papers, Centre for Health Economics, University of York
3. Is an ounce of prevention worth a pound of cure? Estimates of the impact of English public health grant on mortality and morbidity
   Working Papers, Centre for Health Economics, University of York View citations (2)

2018

4. Estimating the marginal productivity of the English National Health Service from 2003/04 to 2012/13
   Working Papers, Centre for Health Economics, University of York View citations (5)
5. Setting research priorities in Global Health:Appraising the value of evidence generation activities to support decision-making in health care
   Working Papers, Centre for Health Economics, University of York

2016

6. Assessing the impact of health care expenditures on mortality using cross-country data
   Working Papers, Centre for Health Economics, University of York View citations (3)
7. Supporting the development of an essential health package: principles and initial assessment for Malawi
   Working Papers, Centre for Health Economics, University of York View citations (3)

2015

8. Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data
   Working Papers, Centre for Health Economics, University of York View citations (13)
9. Country-level cost-effectiveness thresholds: initial estimates and the need for further research
   Working Papers, Centre for Health Economics, University of York View citations (44)

2014

10. Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose?
    Working Papers, Centre for Health Economics, University of York View citations (10)

2013

11. Expected health benefits of additional evidence: Principles, methods and applications
    Working Papers, Centre for Health Economics, University of York View citations (5)
12. Methods for the estimation of the NICE cost effectiveness threshold
    Working Papers, Centre for Health Economics, University of York View citations (49)

2012

13. Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions
    Working Papers, Centre for Health Economics, University of York View citations (25)

2011

14. Uncertainty, evidence and irrecoverable costs: Informing approval, pricing and research decisions for health technologies
    Working Papers, Centre for Health Economics, University of York View citations (3)
15. Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS
    Working Papers, Centre for Health Economics, University of York View citations (12)

2010

16. Appropriate Perspectives for Health Care Decisions
    Working Papers, Centre for Health Economics, University of York View citations (48)

2009

17. Budget allocation and the revealed social rate of time preference for health
    Working Papers, Centre for Health Economics, University of York View citations (4)
    See also Journal Article Budget allocation and the revealed social rate of time preference for health, Health Economics, John Wiley & Sons, Ltd. (2012) View citations (7) (2012)

2008

18. Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions
    Working Papers, Centre for Health Economics, University of York View citations (3)
    See also Journal Article Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions, Journal of Health Economics, Elsevier (2010) View citations (8) (2010)
19. Dimensions of design space: a decision-theoretic approach to optimal research design
    Working Papers, Centre for Health Economics, University of York View citations (1)
20. The NICE Cost-Effectiveness Threshold: What it is and What that Means
    MPRA Paper, University Library of Munich, Germany View citations (76)

2007

21. Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions
    Working Papers, Centre for Health Economics, University of York View citations (14)

2006

22. Defining and characterising structural uncertainty in decision analytic models
    Working Papers, Centre for Health Economics, University of York View citations (6)

2005

23. A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence
    Working Papers, Centre for Health Economics, University of York View citations (8)
24. The value of implementation and the value of information: combined and uneven development
    Working Papers, Centre for Health Economics, University of York View citations (3)

2000

25. Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling
    Working Papers, Centre for Health Economics, University of York View citations (11)

1994

26. Modelling the behaviour of general practitioners: a theoretical foundation for studies of fundholding
    Working Papers, Centre for Health Economics, University of York View citations (3)

Undated

27. An Economic Approach to Clinical Trial Design and Research Priority Setting
    Discussion Papers, Department of Economics, University of York View citations (90)
28. Bayesian Value-of-Information Analysis: An Application to a Policy Model of Alzheimer's Disease
    Discussion Papers, Department of Economics, University of York View citations (7)
29. Effects of Fundholding on the Prescribing and Referral Behavior of General Practitioners
    Discussion Papers, Department of Economics, University of York
30. The Role of Decision Analysis in Structuring the Economic Evaluation of Sequential Clinical Decision Problems
    Discussion Papers, Department of Economics, University of York View citations (1)

Journal Articles

2019

1. Accounting for Timing when Assessing Health-Related Policies
   Journal of Benefit-Cost Analysis, 2019, 10, (S1), 73-105 View citations (5)
   See also Working Paper Accounting for timing when assessing health-related policies, LSE Research Online Documents on Economics (2019) View citations (3) (2019)
2. The Value of Further Research: The Added Value of Individual-Participant Level Data
   Applied Health Economics and Health Policy, 2019, 17, (3), 273-284

2018

3. Comment: Positive tails and normative dogs
   Health Economics, 2018, 27, (10), 1425-1427
4. Discounting in Economic Evaluations
   PharmacoEconomics, 2018, 36, (7), 745-758 View citations (16)
5. How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework
   Health Economics, 2018, 27, (2), e41-e54 View citations (1)
6. Social value and individual choice: The value of a choice‐based decision‐making process in a collectively funded health system
   Health Economics, 2018, 27, (2), e28-e40
7. The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all‐cause and disease specific models of mortality
   Health Economics, 2018, 27, (6), 1017-1023 View citations (10)

2016

8. Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal
   Health Economics, 2016, 25, (8), 933-938 View citations (4)

2015

9. CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS?
   Health Economics, 2015, 24, (1), 1-7 View citations (25)

2013

10. When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development?
    PharmacoEconomics, 2013, 31, (2), 137-149 View citations (2)

2012

11. Budget allocation and the revealed social rate of time preference for health
    Health Economics, 2012, 21, (5), 612-618 View citations (7)
    See also Working Paper Budget allocation and the revealed social rate of time preference for health, Working Papers (2009) View citations (4) (2009)
12. Real Economics Needs to Reflect Real Decisions
    PharmacoEconomics, 2012, 30, (2), 133-136 View citations (3)

2011

13. Dangerous omissions: the consequences of ignoring decision uncertainty
    Health Economics, 2011, 20, (2), 212-224 View citations (13)
14. Discounting and decision making in the economic evaluation of health‐care technologies
    Health Economics, 2011, 20, (1), 2-15 View citations (31)

2010

15. Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions
    Journal of Health Economics, 2010, 29, (1), 170-181 View citations (8)
    See also Working Paper Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions, Working Papers (2008) View citations (3) (2008)
16. Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods
    Health Economics, 2010, 19, (10), 1132-1136 View citations (3)

2009

17. Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations
    Health Policy, 2009, 93, (2-3), 85-92 View citations (29)

2008

18. Uncertainty and value of information when allocating resources within and between healthcare programmes
    European Journal of Operational Research, 2008, 191, (2), 530-539 View citations (13)

2007

19. In recognition of Anthony J. Culyer
    Journal of Health Economics, 2007, 26, (6), 1073-1074
20. OFT, VBP: QED?
    Health Economics, 2007, 16, (6), 545-558 View citations (15)

2006

21. Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion
    Health Economics, 2006, 15, (1), 1-4 View citations (18)
22. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis
    Health Economics, 2006, 15, (4), 373-381 View citations (12)
23. Whither trial‐based economic evaluation for health care decision making?
    Health Economics, 2006, 15, (7), 677-687 View citations (44)

2005

24. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
    Health Economics, 2005, 14, (4), 339-347 View citations (73)

2001

25. A dynamic programming approach to the efficient design of clinical trials
    Journal of Health Economics, 2001, 20, (5), 797-822 View citations (19)
26. Representing uncertainty: the role of cost‐effectiveness acceptability curves
    Health Economics, 2001, 10, (8), 779-787 View citations (80)

2000

27. Selecting treatments: a decision theoretic approach
    Journal of the Royal Statistical Society Series A, 2000, 163, (2), 211-225 View citations (6)

1999

28. Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals
    Health Economics, 1999, 8, (3), 269-274 View citations (35)
29. Redefining the analytical approach to pharmacoeconomics
    Health Economics, 1999, 8, (3), 187-189 View citations (3)
30. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies
    Journal of Health Economics, 1999, 18, (3), 341-364 View citations (129)

Books

2015

1. Methods for the Economic Evaluation of Health Care Programmes
   OUP Catalogue, Oxford University Press View citations (489)

2006

2. Decision Modelling for Health Economic Evaluation
   OUP Catalogue, Oxford University Press View citations (391)

Chapters

2012

1. Decision-making with Uncertainty: The Value of Information
   Chapter 51 in The Elgar Companion to Health Economics, Second Edition, 2012
   Also in Chapter 48 in The Elgar Companion to Health Economics, 2006 (2006)

Editor

1. Journal of Health Economics
   Elsevier